摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(甲氨基)庚酸 | 90227-27-3

中文名称
7-(甲氨基)庚酸
中文别名
——
英文名称
7-Methylamino-heptansaeure
英文别名
7-(Methylamino)heptanoic acid
7-(甲氨基)庚酸化学式
CAS
90227-27-3
化学式
C8H17NO2
mdl
——
分子量
159.228
InChiKey
KBMWCYLQINPRTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    96-97 °C
  • 沸点:
    272.3±23.0 °C(Predicted)
  • 密度:
    0.970±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -2.5
  • 重原子数:
    11
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Separation material comprising phosphoryl choline derivatives
    申请人:Pentracor GmbH
    公开号:EP2957563A1
    公开(公告)日:2015-12-23
    The present invention provides phosphoryl choline derivatives of general formula (I), which are suitable to be immobilized on a solid support to provide a separation material, which bind with both high affinity and high specificity to a protein, more specifically to C-reactive protein and anti-phosphoryl choline antibodies. Said separation materials are particularly useful in the extracorporeal removal of C-reactive protein and anti-phosphoryl choline antibodies from a biological fluid of a patient for prophylaxis and/or treatment of immune dysfunctions and cardiovascular diseases. Also claimed is a device containing a column that comprises separation material made from formula (I) wherein L is a linker as defined in the claims; X is selected from: -SH, -NHR3, -C=CH, -CH=CH2, -N3, -CHO. Also claimed is a separation material of general formula (II): wherein A is a solid support; Y is a group obtainable from the reactive group X.
    本发明提供了一般式(I)的磷酸胆碱衍生物,适合固定在固体支架上,以提供分离材料,其具有与蛋白质高亲和力和高特异性结合的能力,更具体地结合到C-反应蛋白和抗磷酸胆碱抗体。该分离材料在从患者的生物液中外体清除C-反应蛋白和抗磷酸胆碱抗体,以预防和/或治疗免疫功能障碍和心血管疾病方面特别有用。还声明了一种包含由公式(I)制成的分离材料的柱子的装置,其中L是如权利要求中定义的连接剂;X选自:-SH,-NHR3,-C = CH,-CH = CH2,-N3,-CHO。还声明了一种一般式(II)的分离材料:其中A是固体支架; Y是从反应基团X获得的基团。
  • PYRIMIDINE COMPOUND
    申请人:Matsushima Yuji
    公开号:US20110053912A1
    公开(公告)日:2011-03-03
    A novel and excellent method for preventing and/or treating diseases related to a cannabinoid type 2 receptor, based on an agonistic action on a cannabinoid type 2 receptor. It was found that a hetero ring derivative mainly having two substituents, for example, a pyrimidine-5-carboxamide derivative having a substituent amino group at the 2-position, exhibits a potent agonistic action on a cannabinoid type 2 receptor, and can be an agent for preventing and/or treating diseases related to a cannabinoid type 2 receptor such as inflammatory diseases, pain, and the like.
    一种预防和/或治疗与大麻素2型受体相关疾病的新颖优秀方法,基于对大麻素2型受体的激动作用。发现一种异核环衍生物主要具有两个取代基,例如,在2-位置具有取代基氨基的嘧啶-5-羧酰胺衍生物,表现出对大麻素2型受体的强效激动作用,可以成为预防和/或治疗与大麻素2型受体相关疾病,如炎症性疾病、疼痛等的药物。
  • ORALLY AVAILABLE VIRIDIOFUNGIN DERIVATIVE POSSESSING ANTI-HCV ACTIVITY
    申请人:Chugai Seiyaku Kabushiki Kaisha
    公开号:US20150210666A1
    公开(公告)日:2015-07-30
    An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
    本发明的目的是提供一种可口服的抗丙型肝炎病毒药物化合物。本发明涉及一种由式(1)所表示的化合物或其药学上可接受的盐。该化合物具有抗丙型肝炎病毒的活性,是一种有用的药物。
  • PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS
    申请人:G.D. Searle & Co.
    公开号:EP0910351A1
    公开(公告)日:1999-04-28
  • SEPARATION MATERIAL COMPRISING PHOSPHORYL CHOLINE DERIVATIVES
    申请人:Pentracor GmbH
    公开号:EP3041852A1
    公开(公告)日:2016-07-13
查看更多